Emerging antifungal treatment failure of dermatophytosis in Europe: take care or it may become endemic.
J Eur Acad Dermatol Venereol
; 35(7): 1582-1586, 2021 Jul.
Article
in En
| MEDLINE
| ID: mdl-33768571
ABSTRACT
BACKGROUND:
Dermatophytosis is a world-wide distributed common infection. Antifungal drug resistance in dermatophytosis used to be rare, but unfortunately the current Indian epidemic of atypical widespread recalcitrant and terbinafine-resistant dermatophytosis is spreading and has sporadically been reported in Europe.OBJECTIVES:
To explore the occurrence of clinical and mycological proven antifungal drug resistance in dermatophytes in Europe.METHODS:
A standardized questionnaire was distributed through the EADV Task Force of Mycology network to dermatologists in Europe.RESULTS:
Representatives from 20 countries completed the questionnaires of which 17 (85 %) had observed clinical and/or mycological confirmed antifungal resistance, two countries published cases of antifungal resistance and one country had no known cases.CONCLUSIONS:
This pilot study confirms that both clinical and mycological antifungal resistance exist in Europe.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Tinea
/
Antifungal Agents
Limits:
Humans
Country/Region as subject:
Europa
Language:
En
Journal:
J Eur Acad Dermatol Venereol
Journal subject:
DERMATOLOGIA
/
DOENCAS SEXUALMENTE TRANSMISSIVEIS
Year:
2021
Type:
Article